Logo image of CTMX

CYTOMX THERAPEUTICS INC (CTMX) Stock Earnings & Estimates

USA - NASDAQ:CTMX - US23284F1057 - Common Stock

3.615 USD
-0.12 (-3.34%)
Last: 10/21/2025, 8:07:04 PM
3.73 USD
+0.11 (+3.18%)
After Hours: 10/21/2025, 8:07:04 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CTMX revenue by date.CTMX revenue by date.
53.2M
42.63%
101.214M
90.25%
138.103M
36.45%
95.065M
-31.16%
44.23M
-53.47%
36.414M
-17.67%
49.886M
37.00%
122.79M
146.14%
191.37M
55.85%
276.89M
44.69%
378.14M
36.57%
EBITDA
YoY % growth
CTMX ebitda by date.CTMX ebitda by date.
-91.2M
19.51%
-4.309M
95.28%
26.763M
721.10%
22.44M
-16.15%
-5.1M
-122.73%
-14.28M
-180.00%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CTMX ebit by date.CTMX ebit by date.
-93.6M
19.31%
-6.484M
93.07%
24.995M
485.49%
4.714M
-81.14%
-62.518M
-1,426.22%
-80.091M
-28.11%
-65.899M
17.72%
-13.861M
78.97%
37.858M
373.12%
102.37M
170.41%
179.47M
75.32%
Operating Margin
CTMX operating margin by date.CTMX operating margin by date.
-175.94%-6.41%18.10%4.96%-141.35%-219.95%-132.10%-11.29%19.78%36.97%47.46%
EPS
YoY % growth
CTMX eps by date.CTMX eps by date.
-1.52
-16.03%
-0.02
98.68%
0.39
2,050.00%
0.03
-91.46%
-0.32
-1,058.49%
-0.41
-28.54%
-0.31
24.65%
0.01
103.30%
0.34
3,250.00%
0.78
128.36%
1.11
41.83%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.05
-173.78%
-0.05
-123.84%
-0.07
-126.44%
-0.09
-9,080.00%
-0.10
-90.93%
-0.10
-86.05%
Revenue
Q2Q % growth
11.858M
-64.53%
12.38M
-67.50%
10.098M
-80.17%
7.548M
-59.55%
7.548M
-36.35%
7.548M
-39.03%
EBITDA
Q2Q % growth

-100.00%
1.02M
-94.75%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-9.039M
-319.88%
-9.453M
-153.47%
-10.372M
-145.85%
-13.177M
-924.68%
-14.197M
-57.06%
-15.982M
-69.07%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
0.00
98.75%
-0.080.0898.72%
Q1 2025
Q2Q % growth
0.27
58.82%
0.130.14113.47%
Q4 2024
Q2Q % growth
0.23
2,200.00%
-0.200.43215.22%
Q3 2024
Q2Q % growth
0.07
75.00%
-0.180.25139.87%
Q2 2024
Q2Q % growth
-0.08
-300.00%
-0.150.0745.28%
Q1 2024
Q2Q % growth
0.17
440.00%
-0.080.25301.22%
Q4 2023
Q2Q % growth
0.01
102.33%
-0.030.04134.32%
Q3 2023
Q2Q % growth
0.04
111.43%
-0.190.23120.76%
Q2 2023
Q2Q % growth
-0.02
94.59%
-0.210.1990.44%
Q1 2023
Q2Q % growth
-0.05
86.49%
-0.110.0653.65%
Q4 2022
Q2Q % growth
-0.43
-7.50%
-0.24-0.19-78.96%
Q3 2022
Q2Q % growth
-0.35 -0.31-0.04-12.30%
Q2 2022
Q2Q % growth
-0.37
-23.33%
-0.370.00-0.76%
Q1 2022
Q2Q % growth
-0.37
-42.31%
-0.370.000.16%
Q4 2021
Q2Q % growth
-0.40
-25.00%
-0.29-0.11-38.95%
Q3 2021
Q2Q % growth
-0.35
-9.37%
-0.32-0.03-9.80%
Q2 2021
Q2Q % growth
-0.30
11.76%
-0.330.037.88%
Q1 2021
Q2Q % growth
-0.26
-200.00%
-0.350.0926.29%
Q4 2020
Q2Q % growth
-0.32
58.97%
-0.510.1937.70%
Q3 2020
Q2Q % growth
-0.32
38.46%
-0.490.1734.13%
Q2 2020
Q2Q % growth
-0.34
46.88%
0.16-0.50-313.13%
Q1 2020
Q2Q % growth
0.26
183.87%
-0.470.73155.29%
Q4 2019
Q2Q % growth
-0.78 -0.48-0.30-62.77%
Q3 2019
Q2Q % growth
-0.52 -0.520.000.95%
Q2 2019
Q2Q % growth
-0.64 -0.58-0.06-10.45%
Q1 2019
Q2Q % growth
-0.31 -0.540.2343.08%
CTMX Yearly EPS VS EstimatesCTMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
18.658M
-25.71%
15.076M3.582M23.76%
Q1 2025
Q2Q % growth
50.917M
22.80%
31.455M19.462M61.87%
Q4 2024
Q2Q % growth
38.093M
43.17%
19.805M18.288M92.34%
Q3 2024
Q2Q % growth
33.432M
26.71%
17.865M15.567M87.14%
Q2 2024
Q2Q % growth
25.115M
1.58%
20.395M4.72M23.14%
Q1 2024
Q2Q % growth
41.463M
76.45%
21.863M19.6M89.65%
Q4 2023
Q2Q % growth
26.607M
2,700.74%
21.464M5.143M23.96%
Q3 2023
Q2Q % growth
26.384M
136.63%
14.424M11.96M82.92%
Q2 2023
Q2Q % growth
24.724M
92.40%
14.159M10.565M74.62%
Q1 2023
Q2Q % growth
23.499M
159.94%
19.98M3.519M17.61%
Q4 2022
Q2Q % growth
950K
107.58%
18.204M-17.254M-94.78%
Q3 2022
Q2Q % growth
11.15M
-36.61%
18.516M-7.366M-39.78%
Q2 2022
Q2Q % growth
12.85M
-21.12%
18.259M-5.409M-29.62%
Q1 2022
Q2Q % growth
9.04M
-43.39%
21.077M-12.037M-57.11%
Q4 2021
Q2Q % growth
-12.53M
-176.54%
25.003M-37.533M-150.11%
Q3 2021
Q2Q % growth
17.59M
-1.12%
18.446M-856K-4.64%
Q2 2021
Q2Q % growth
16.29M
-1.93%
17.202M-912K-5.30%
Q1 2021
Q2Q % growth
15.97M
-67.80%
15.735M235K1.49%
Q4 2020
Q2Q % growth
16.37M
97.71%
15.718M652K4.15%
Q3 2020
Q2Q % growth
17.79M
66.11%
16.67M1.12M6.72%
Q2 2020
Q2Q % growth
16.61M
84.35%
49.174M-32.564M-66.22%
Q1 2020
Q2Q % growth
49.59M
68.16%
20.276M29.314M144.57%
Q4 2019
Q2Q % growth
8.28M 17.719M-9.439M-53.27%
Q3 2019
Q2Q % growth
10.71M 18.424M-7.714M-41.87%
Q2 2019
Q2Q % growth
9.01M 16.913M-7.903M-46.73%
Q1 2019
Q2Q % growth
29.49M 13.126M16.364M124.67%
CTMX Yearly Revenue VS EstimatesCTMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.79% 39.73% 89.94% 115.37%
Revenue-3.12% -1.06% -0.79% 5.59%